Back to search

Article

The combination of Bromelain and Acetylcysteine (BromAc) synergistically inactivates SARS-CoV-2

2020-09-08

Abstract excerpt

<h4>Background and objectives</h4> SARS-CoV-2 infection is the cause of a worldwide pandemic, currently with limited therapeutic options. Whilst vaccines are at the forefront of the therapeutic initiative, drug repurposing remains a promising approach for SARS-CoV-2 treatment. BromAc (Bromelain & Acetylcysteine) has synergistic action against glycoproteins by the synchronous breakage of glycosidic linkages and di...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
73d55e81-c0fe-56eb-ad7e-df64f85190b9
DOI
10.1101/2020.09.07.286906
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The combination of Bromelain and Acetylcysteine (BromAc) synergistically inactivates SARS-CoV-2DOI 10.1101/2020.09.07.286906
Select a neighboring publication to make it the new centre.